Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

8.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

482
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
482
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RECITE this mantra in chemotherapy-induced thrombocytopenia: treat patients, not platelets.

Nature reviews. Clinical oncology·2026
Same author

Household income sources and mobility drivers of dietary diversity among refugees with hypertension and/or type 2 diabetes in Bidibidi Settlement, Uganda.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
Same author

Downplaying toxicities in cancer drug trials is not acceptable.

Nature medicine·2026
Same author

Critical Appraisal: Prognostic versus Predictive Surrogate Markers in Oncology.

Journal of the National Cancer Institute·2026
Same author

Factors influencing PrEP adoption in sexual health clinics within Ontario's public health system: a qualitative study using the Consolidated Framework for Implementation Research (CFIR).

Frontiers in public health·2026
Same author

Did ATOMIC really improve on the standard of care for mismatch repair-deficient colon cancer?

Nature reviews. Clinical oncology·2026
Same journal

Use of comprehensive geriatric assessment among oncologists in Uruguay: perceptions, practices and barriers.

Ecancermedicalscience·2026
Same journal

Age and sex-based differences in therapy preferences among patients with cancer: evidence from a novel therapy preference scale.

Ecancermedicalscience·2026
Same journal

Prospective evaluation of locoregional control in oral cavity squamous cell carcinoma with lower or mid infratemporal fossa involvement treated with surgery and adjuvant concurrent chemoradiotherapy.

Ecancermedicalscience·2026
Same journal

Trends in incidence and mortality of acute and chronic leukaemias in Brazil: challenges and advances over three decades.

Ecancermedicalscience·2026
Same journal

A scoping review on pathways/models/frameworks for palliative care provision for cancer patients while admitted at hospitals within sub-Saharan Africa.

Ecancermedicalscience·2026
Same journal

Cost-effectiveness and budget impact of breast cancer genetic profiling in Egypt.

Ecancermedicalscience·2026
See all related articles

Related Experiment Video

Updated: Oct 28, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.5K

Oncology training programmes for general practitioners: a scoping review.

Bishal Gyawali1,2,3,4, Matthew Jalink3,4, Sophie Marie Anne Effing5

  • 1Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, 10 Stuart Street, 2nd Level, Kingston, ON K7L 3N6, Canada.

Ecancermedicalscience
|July 16, 2021
PubMed
Summary
This summary is machine-generated.

Training General Practitioners (GPs) in Oncology (GPOs) can help address cancer care workforce shortages. This review identified 12 GPO training programs globally, highlighting varied durations and delivery methods.

Keywords:
curriculumgeneral practicemedical oncology trainingoncologytraining

More Related Videos

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.2K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.6K

Related Experiment Videos

Last Updated: Oct 28, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.5K
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.2K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.6K

Area of Science:

  • Oncology
  • Medical Education
  • Public Health

Background:

  • Rising global cancer burden necessitates innovative healthcare workforce solutions.
  • Shortage of medical oncologists impacts cancer care delivery, particularly in low-and-middle-income countries (LMICs).
  • Training General Practitioners (GPs) in Oncology (GPOs) offers a strategy for task-sharing and task-shifting.

Purpose of the Study:

  • To conduct a scoping review to identify and characterize existing global training programs and curricula for GPOs.
  • To inform the development of GPO programs to address cancer workforce deficits.

Main Methods:

  • Scoping review methodology employed.
  • Searched EMBASE, Medline/PubMed, and Education Source for relevant articles.
  • Included all study types, with a two-stage screening process by two independent reviewers.

Main Results:

  • Twelve GPO training programs and curricula were identified (5 from peer-reviewed literature, 7 from grey literature).
  • All identified programs were from high-income countries.
  • Program durations varied significantly, from short workshops (1.5 days) to longer courses (up to 2 years), utilizing didactic lectures and clinical rotations.

Conclusions:

  • A limited number of heterogeneous studies and grey literature sources describe GPO training programs.
  • The findings provide a basis for fostering collaboration to develop GPO programs.
  • GPO programs have the potential to mitigate workforce shortages in cancer care, especially in LMICs.